1. Home
  2. PLBY vs OSUR Comparison

PLBY vs OSUR Comparison

Compare PLBY & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PLBY

PLBY Group Inc.

HOLD

Current Price

$1.92

Market Cap

202.6M

ML Signal

HOLD

Logo OraSure Technologies Inc.

OSUR

OraSure Technologies Inc.

HOLD

Current Price

$2.69

Market Cap

174.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLBY
OSUR
Founded
1953
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
202.6M
174.3M
IPO Year
N/A
1986

Fundamental Metrics

Financial Performance
Metric
PLBY
OSUR
Price
$1.92
$2.69
Analyst Decision
Strong Buy
Hold
Analyst Count
1
2
Target Price
$3.00
$3.00
AVG Volume (30 Days)
493.5K
661.1K
Earning Date
11-12-2025
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$119,510,000.00
$125,703,000.00
Revenue This Year
$4.97
N/A
Revenue Next Year
$8.38
$3.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$2.08
52 Week High
$2.53
$4.22

Technical Indicators

Market Signals
Indicator
PLBY
OSUR
Relative Strength Index (RSI) 54.65 60.17
Support Level $1.82 $2.55
Resistance Level $2.04 $2.81
Average True Range (ATR) 0.09 0.11
MACD 0.00 0.03
Stochastic Oscillator 53.85 76.84

Price Performance

Historical Comparison
PLBY
OSUR

About PLBY PLBY Group Inc.

Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

Share on Social Networks: